Please use this identifier to cite or link to this item:
Title: BRAF Mutations-A Good News Story for Immune Checkpoint Inhibitors in Oncogene-Addicted NSCLC?
Authors: Arulananda, Surein;Mitchell, Paul L R
Affiliation: Cancer Immuno-Biology Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia
School of Cancer Medicine, La Trobe University, Heidelberg, Australia
Department of Medical Oncology, Austin Health, Heidelberg, Victoria, Australia
Department of Medicine, University of Melbourne, Parkville, Australia
Issue Date: Aug-2018
EDate: 2018-07-02
Citation: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2018; 13(8): 1055-1057
DOI: 10.1016/j.jtho.2018.06.002
PubMed URL: 30056857
Type: Editorial
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.

Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.